367 related articles for article (PubMed ID: 15492945)
1. ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention.
Jungers P; Joly D; Barbey F; Choukroun G; Daudon M
Am J Kidney Dis; 2004 Nov; 44(5):799-805. PubMed ID: 15492945
[TBL] [Abstract][Full Text] [Related]
2. [Nephrolithiasis-induced ESRD: frequency, causes and prevention].
Jungers P; Joly D; Barbey F; Choukroun G; Daudon M
Nephrol Ther; 2005 Nov; 1(5):301-10. PubMed ID: 16895699
[TBL] [Abstract][Full Text] [Related]
3. [Inherited monogenic kidney stone diseases: recent diagnostic and therapeutic advances].
Jungers P; Joly D; Blanchard A; Courbebaisse M; Knebelmann B; Daudon M
Nephrol Ther; 2008 Jul; 4(4):231-55. PubMed ID: 18499551
[TBL] [Abstract][Full Text] [Related]
4. Nephrolithiasis-induced end stage renal disease.
Ounissi M; Gargueh T; Mahfoudhi M; Boubaker K; Hedri H; Goucha R; Abderrahim E; Ben Hamida F; Ben Abdallah T; El Younsi F; Ben Maiz H; Kheder A
Int J Nephrol Renovasc Dis; 2010; 3():21-6. PubMed ID: 21694924
[TBL] [Abstract][Full Text] [Related]
5. [A nephrologist's tasks in nephrolithiasis].
Marangella M
G Ital Nefrol; 2005; 22(1):16-27. PubMed ID: 15786374
[TBL] [Abstract][Full Text] [Related]
6. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
Ekeruo WO; Tan YH; Young MD; Dahm P; Maloney ME; Mathias BJ; Albala DM; Preminger GM
J Urol; 2004 Jul; 172(1):159-63. PubMed ID: 15201761
[TBL] [Abstract][Full Text] [Related]
7. Type 2 diabetes increases the risk for uric acid stones.
Daudon M; Traxer O; Conort P; Lacour B; Jungers P
J Am Soc Nephrol; 2006 Jul; 17(7):2026-33. PubMed ID: 16775030
[TBL] [Abstract][Full Text] [Related]
8. Calcium-uric acid nephrolithiasis.
Coe FL
Arch Intern Med; 1978 Jul; 138(7):1090-3. PubMed ID: 666467
[TBL] [Abstract][Full Text] [Related]
9. Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure.
Nasr SH; Sethi S; Cornell LD; Milliner DS; Boelkins M; Broviac J; Fidler ME
Nephrol Dial Transplant; 2010 Jun; 25(6):1909-15. PubMed ID: 20064951
[TBL] [Abstract][Full Text] [Related]
10. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
Wong CF; McCarthy M; Howse ML; Williams PS
Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
[TBL] [Abstract][Full Text] [Related]
12. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
13. Current status of end-stage renal disease care in South Asia.
Jha V
Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
[TBL] [Abstract][Full Text] [Related]
14. Eicosapentaenoic acid has a preventive effect on the recurrence of nephrolithiasis.
Yasui T; Suzuki S; Itoh Y; Tozawa K; Tokudome S; Kohri K
Urol Int; 2008; 81(2):135-8. PubMed ID: 18758209
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of ESRD treated with renal dialysis in France in 2003.
Macron-Noguès F; Vernay M; Ekong E; Thiard B; Salanave B; Fender P; Allemand H
Am J Kidney Dis; 2005 Aug; 46(2):309-15. PubMed ID: 16112050
[TBL] [Abstract][Full Text] [Related]
16. Renal pathology in end-stage renal disease associated with paraplegia.
Barton CH; Vaziri ND; Gordon S; Tilles S
Paraplegia; 1984 Feb; 22(1):31-41. PubMed ID: 6718046
[TBL] [Abstract][Full Text] [Related]
17. Frequency of renal stone disease in patients with urinary tract infection.
Jan H; Akbar I; Kamran H; Khan J
J Ayub Med Coll Abbottabad; 2008; 20(1):60-2. PubMed ID: 19024188
[TBL] [Abstract][Full Text] [Related]
18. Metabolic abnormalities associated with calyceal diverticular stones.
Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
[TBL] [Abstract][Full Text] [Related]
19. [Metabolic changes in 2612 patients with nephrolithiasis].
del Valle E; Spivacow R; Zanchetta JR
Medicina (B Aires); 1999; 59(5 Pt 1):417-22. PubMed ID: 10684159
[TBL] [Abstract][Full Text] [Related]
20. Duration of end-stage renal disease and kidney transplant outcome.
Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
